Literature DB >> 9776161

The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer.

S Law1, C Arcilla, K M Chu, J Wong.   

Abstract

BACKGROUND: Microscopic tumor infiltration of the resection margin after esophageal resection is implicated to influence anastomotic leakage, tumor recurrence rates, and long-term survival.
METHODS: Patients with tumor infiltration of resection margin (RM+) and those without (RM-) were compared.
RESULTS: Of 604 patients, 45 (7.5%) were RM+. Patients in the RM+ group had more palliative resections, 76% versus 56%, P = 0.01. Anastomotic leakage rates were 2.2% (RM+) and 4.1% (RM-), P = 1.0. Excluding hospital deaths, anastomotic recurrences developed in 10.3% in the RM+ group and 4.9% in the RM- groups, P = 0.15. Although a positive margin did not increase anastomotic recurrence, a shorter resection margin correlated with such recurrence. The mean (SEM) lengths of resection margins in surgical specimens were 2.7 cm (0.3) and 4.4 cm (0.1) for those with and without recurrence, P < 0.001. Median survival time were 8.8 months (RM+) and 15 months (RM-), P = 0.007.
CONCLUSIONS: Histologic infiltration of resection margins did not influence leakage rate. Anastomotic recurrence was related to the length of resection margin.

Entities:  

Mesh:

Year:  1998        PMID: 9776161     DOI: 10.1016/s0002-9610(98)00140-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  16 in total

1.  Totally laparoscopic transhiatal esophago-gastrectomy without thoracic or cervical access. The least invasive surgery for adenocarcinoma of the cardia?

Authors:  R Costi; J Himpens; J Bruyns; G B Cadière
Journal:  Surg Endosc       Date:  2004-03-19       Impact factor: 4.584

2.  The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma.

Authors:  Shao-bin Chen; Hong-rui Weng; Geng Wang; Di-tian Liu; Hua Li; Hao Zhang; Yu-ping Chen
Journal:  J Cancer Res Clin Oncol       Date:  2015-09-02       Impact factor: 4.553

Review 3.  Current management of esophageal cancer.

Authors:  Simon Law; John Wong
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

Review 4.  Quality Management and Key Performance Indicators in Oncologic Esophageal Surgery.

Authors:  Ines Gockel; Constantin Johannes Ahlbrand; Michael Arras; Elke Maria Schreiber; Hauke Lang
Journal:  Dig Dis Sci       Date:  2015-07-16       Impact factor: 3.199

Review 5.  [R1 resection of esophageal carcinoma].

Authors:  I Gockel; C Wittekind
Journal:  Chirurg       Date:  2017-09       Impact factor: 0.955

6.  Unexpected Microscopically Positive Proximal Resection Margins in Esophageal Squamous Cell Carcinoma After Chemoradiotherapy: Predictors and Prognostic Significance.

Authors:  Chien-Hung Chiu; Yin-Kai Chao; Yu-Wen Wen; Hsien-Kun Chang; Chen-Kan Tseng; Yun-Hen Liu
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

7.  The Role of Adjuvant Therapy in Patients With Margin-Positive (R1) Esophagectomy: A National Analysis.

Authors:  Vignesh Raman; Oliver K Jawitz; Soraya L Voigt; Chi-Fu J Yang; Thomas A D'Amico; David H Harpole
Journal:  J Surg Res       Date:  2020-01-08       Impact factor: 2.192

8.  A study of contractility of proximal surgical margin in esophageal cancer.

Authors:  Jalaluddin Khoshnevis; Afshin Moradi; Eznollah Azargashb; Barmak Gholizade; Mohammad Reza Sobhiyeh
Journal:  Iran J Cancer Prev       Date:  2013

9.  Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.

Authors:  Andrew P Barbour; Nabil P Rizk; Mithat Gonen; Laura Tang; Manjit S Bains; Valerie W Rusch; Daniel G Coit; Murray F Brennan
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

10.  Incidence and risk factors predisposing anastomotic leak after transhiatal esophagectomy.

Authors:  Abbas Tabatabai; Mozaffar Hashemi; Gholamreza Mohajeri; Mojtaba Ahmadinejad; Ishfaq Abass Khan; Saeid Haghdani
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.